S Behrman. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » AdultAntipsychotic Agents/adverse effectsAntipsychotic Agents/therapeutic useChlorpromazine/adverse effectsChlorpromazine/therapeutic useDepression/drug therapyFemaleHumansHyperemesis Gravidarum/drug therapyIntellectual Disability/drug therapyMaleMiddle AgedMutism/chemically inducedPregnancyPromazine/adverse effectsPromazine/therapeutic useSchizophrenia/drug therapyTrifluoperazine/adverse effectsTrifluoperazine/therapeutic use
Substances： See more » Antipsychotic AgentsTrifluoperazinePromazineChlorpromazine
Year: 1972 PMID： 4405372 DOI： 10.1192/bjp.121.6.599
Source DB: PubMed Journal: Br J Psychiatry ISSN： 0007-1250 Impact factor: 9.319